What is Somatic Hypermutation
Somatic hypermutation (SHM) is a process that occurs in B cells, where the variable regions of antibodies undergo targeted mutations to increase their affinity and specificity towards antigens. This process is crucial for generating a diverse repertoire of antibodies capable of recognizing a wide array of pathogens.
The key enzyme responsible for initiating SHM is activation-induced cytidine deaminase (AID), which introduces changes in the DNA sequence, particularly at specific motifs known as hotspots.
How AID Triggers Mutations
AID localizes to the variable regions of immunoglobulin genes and preferentially deaminates cytosine residues to uracil. This deamination event is a critical step that sets off a cascade of events leading to DNA damage and subsequent repair, which often results in mutations.
The AID enzyme has a preference for specific motifs such as WRC (where W can be A or T, R can be G or A) and RGYW (where Y can be C or T), making these regions hotspots for mutation.
Types of Mutations Induced by SHM
SHM primarily results in transitions (changes from purine to purine, or pyrimidine to pyrimidine) and transversions (changes between purines and pyrimidines). The balance between these types of mutations can significantly influence the outcome of antibody evolution.
The fidelity of repair pathways plays a crucial role in determining whether the mutation is silent, synonymous, or nonsynonymous, thereby affecting the functional diversity of antibodies.
Implications and Applications
Understanding SHM and its regulation by AID has profound implications for both basic immunology and therapeutic strategies. It provides insights into how the immune system can adapt to new pathogens and has applications in developing vaccines and treatments for diseases.
Moreover, studying SHM can help in understanding the development of autoimmune disorders and cancer, where uncontrolled mutations can lead to pathogenic outcomes.
Frequently asked questions
What is AID and why is it important?
AID (activation-induced cytidine deaminase) is a crucial enzyme that initiates somatic hypermutation in B cells. It is essential for generating diverse antibody repertoires to combat various pathogens.
How do transitions and transversions differ, and why are they important?
Transitions involve changes between purines (A or G) or pyrimidines (C or T), while transversions change a purine for a pyrimidine or vice versa. These differences affect the stability of the DNA structure and can lead to different types of mutations with varying impacts on protein function.
Can SHM occur in other cell types besides B cells?
SHM is primarily associated with B cells, but similar processes involving cytidine deaminases have been observed in other cell types and can contribute to genetic diversity or mutagenesis under certain conditions.
How does the balance between faithful and error-prone repair pathways affect SHM outcomes?
The balance between these repair pathways determines the type of mutations that occur. AID-induced deamination followed by error-prone repair can lead to a higher frequency of transitions, while more faithful repair may result in fewer but potentially more stable mutations.
Try it live
Everything above runs in your browser — open AID Hotspot Mutagenesis: Somatic Hypermutation and change the parameters while it is running. Nothing is installed, nothing is uploaded, the whole model lives in one tab.
▶ Open AID Hotspot Mutagenesis: Somatic Hypermutation simulation